Cogent Biosciences (COGT) Shares Outstanding (2017 - 2026)

Cogent Biosciences (COGT) has reported Shares Outstanding (Entity) for 10 consecutive years, with $170.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 49.99% year-over-year to $170.8 million; the TTM figure through Mar 2026 stood at $170.8 million (up 49.99% YoY), while the FY2025 annual figure was $128.9 million, up 16.69% from the prior year.
• Shares Outstanding (Entity) advanced to $170.8 million in Q1 2026 per COGT's latest filing, from $128.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $170.8 million in Q1 2026 and bottomed at $45.8 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $97.5 million across 5 years, with a median of $95.6 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 75.3% — and 2025, when it increased 4.19%.
• Cogent Biosciences' Shares Outstanding (Entity) stood at $69.9 million in 2022, then increased by 23.22% to $86.1 million in 2023, then grew by 28.26% to $110.5 million in 2024, then increased by 16.69% to $128.9 million in 2025, then jumped by 32.49% to $170.8 million in 2026.
• Business Quant data shows COGT's Shares Outstanding (Entity) at $170.8 million in Q1 2026, $128.9 million in Q4 2025, and $139.8 million in Q3 2025.